How to Reduce Fatty Liver Quickly: What Actually Works

Losing roughly five to ten percent of your body weight is the single most effective way to reduce liver fat, and depending on the approach, measurable improvement can show up on imaging within weeks. A year-long lifestyle trial found that participants who hit that ten-percent threshold saw resolution of liver inflammation in nine out of ten cases, with nearly half also showing reversal of scarring. But weight loss is not the only lever. Exercise lowers liver fat even when the scale does not budge, certain dietary shifts target the specific metabolic pathways that pack fat into liver cells, and a new wave of medications can slash liver fat by a third or more in people who qualify. The challenge is sorting the strategies with strong evidence from the ones that sound promising but remain unproven.

How Much Weight Loss Actually Matters

The relationship between weight loss and liver-fat reduction is not linear; there are thresholds where the benefits jump sharply. In a 52-week trial of 261 people with biopsy-confirmed liver inflammation, those who lost at least five percent of their body weight saw clear reductions in liver-disease severity compared to those who lost less. The real inflection point was ten percent: every single participant who reached that mark improved, about 90 percent had their liver inflammation fully resolve, and 45 percent showed regression of fibrosis (the scarring that drives long-term liver damage).¹ The sobering caveat is that only about one in ten participants actually achieved that degree of weight loss over a year. So while ten percent is the gold standard, even five percent is worth pursuing and delivers meaningful liver benefits.

Speed matters to people searching for quick results. The good news is that liver fat responds earlier than many other markers. Some interventions show measurable reductions in liver fat within nine to twelve weeks, well before fibrosis or inflammation scores fully normalize. That early drop in fat is encouraging, but it is worth understanding that reversing inflammation and especially fibrosis takes longer, often six months to a year or more of sustained effort.

What to Eat and What to Cut First

If you change only one dietary habit, cutting added sugars, especially fructose, delivers an outsized return. Fructose is metabolized almost exclusively by the liver, and it drives a process where the liver converts sugar directly into fat. This happens more aggressively with fructose than with other sugars because fructose bypasses several of the usual metabolic checkpoints: it does not need insulin to be processed, it directly ramps up the enzymes that build fat, and it depletes the liver’s energy stores in the process.² In a striking study of children with obesity who were heavy fructose consumers, simply restricting fructose for nine days, without reducing total calories, cut liver fat nearly in half (median dropped from about 7 percent to under 4 percent) and slashed the liver’s fat-building activity dramatically.³ That is one of the fastest documented improvements in liver fat from any single dietary change.

The practical implication: soft drinks, fruit juices, sweetened teas, and processed foods with added sugars (especially those containing high-fructose corn syrup) are the first things to reduce. You do not need to swear off fruit; whole fruit contains fructose bound up with fiber, water, and micronutrients, and it arrives at the liver slowly. The problem is concentrated liquid fructose from beverages and ultra-processed foods.

Beyond sugar reduction, the overall dietary pattern matters. A Mediterranean-style diet that is also lower in refined carbohydrates has been shown to reduce liver fat more than a standard low-fat diet over 18 months, even after accounting for differences in belly fat.⁴ A small pilot trial compared a very low-energy ketogenic diet against a Mediterranean diet and found the ketogenic approach produced a larger relative reduction in liver fat (about 77 percent versus 14 percent) over 12 weeks, though it also produced much more weight loss, making it hard to separate the diet’s direct effects from the weight-loss effects.⁵ Aggressive calorie restriction works fast, but the real question is sustainability. The Mediterranean approach is easier to maintain long-term, and its benefits accumulate over months.

Exercise Lowers Liver Fat Even Without Weight Loss

One of the most encouraging findings for people who struggle to lose weight is that exercise reduces liver fat independently of what the scale says. A meta-analysis of trials that specifically looked at exercise without significant weight change found that physical activity on its own produced a meaningful reduction in liver fat content, along with improvements in liver enzymes and blood lipids.⁶ Both aerobic exercise and resistance training are effective.⁷

Resistance training deserves special attention. An eight-week trial found that lifting weights three times per week produced a 13 percent relative reduction in liver fat without any change in body weight, total body fat, or belly fat.⁸ That matters for anyone who hears “lose weight” and feels stuck: you can improve your liver health by getting stronger, even if your weight stays the same. The mechanisms likely involve improved insulin sensitivity in muscle tissue and changes in how fat is trafficked around the body.

There is also a longer-term benefit to building muscle. A six-year observational study found that increases in skeletal muscle mass were associated with significant improvements in markers of liver fat accumulation.⁹ So while cardio and resistance training both help in the short term, building and maintaining muscle appears to offer ongoing protection.

Intermittent Fasting Versus Calorie Restriction

Intermittent fasting has gained enormous popularity, and people with fatty liver often ask whether it offers something extra beyond ordinary calorie cutting. The honest answer from current trials is: probably not, but it is a perfectly valid alternative if it is easier for you to follow. A randomized trial comparing time-restricted eating (eating within an eight-hour window) against standard daily calorie restriction found nearly identical reductions in liver fat at both six and twelve months, with no statistically significant difference between the two approaches.¹⁰ Both groups saw liver fat drop by roughly eight percentage points at six months, along with comparable improvements in liver stiffness, body weight, and metabolic risk factors.

A different trial tested 5:2 intermittent fasting (eating normally five days a week and sharply restricting calories on two days) against daily calorie restriction over 12 weeks. The 5:2 group actually did better on several liver measures: fewer participants still had moderate or worse fatty liver on ultrasound at the end of the trial (about a third versus nearly two-thirds in the daily restriction group).¹¹ That is an intriguing result, though it is a single trial and the numbers are small. The takeaway is practical: if a fasting schedule makes it easier for you to sustain an overall calorie deficit, it works at least as well as traditional dieting for liver fat reduction, and it may offer some additional benefits for certain people.

Medications That Target Liver Fat

For people whose fatty liver has progressed to inflammation and scarring, lifestyle changes alone may not be enough, or may not work fast enough. The medication landscape has shifted dramatically in recent years.

Resmetirom (brand name Rezdiffra) became the first drug approved specifically for fatty liver disease with fibrosis in 2024. It works by activating thyroid hormone receptors in the liver, essentially speeding up the liver’s own fat-burning machinery. In a large phase 3 trial, the 100-mg dose achieved resolution of liver inflammation in about 30 percent of patients (versus roughly 10 percent on placebo) and improved fibrosis by at least one stage in about 26 percent (versus 14 percent on placebo).¹² Meta-analyses of its trials show it reduces liver fat (measured by MRI) by roughly 28 to 36 percentage points more than placebo, depending on the dose, a substantial effect.¹³ Resmetirom also lowers LDL cholesterol, which is a useful secondary benefit in a population that tends to have elevated cardiovascular risk.

GLP-1 receptor agonists, the class of drugs that includes semaglutide (Ozempic, Wegovy), were originally developed for diabetes and obesity but have shown potent effects on liver fat. One study found that semaglutide reduced liver fat by about a third, and the decrease did not simply track with weight loss; it appeared to work partly by suppressing the liver’s own fat-production pathway.¹⁴ Tirzepatide, a newer dual-action drug in the same family, has shown similar liver benefits in preclinical and early clinical work, reducing liver fat accumulation, inflammation, and fibrosis markers.¹⁵ These drugs are not yet specifically approved for fatty liver disease in most countries, but many doctors prescribe them off-label when a patient has both obesity and significant liver involvement.

Vitamin E, Pioglitazone, and the Evidence Behind Them

Before resmetirom arrived, two older treatments carried the most evidence: high-dose vitamin E and pioglitazone (a diabetes drug). The landmark PIVENS trial tested both against placebo in people with biopsy-confirmed liver inflammation who did not have diabetes. Vitamin E at 800 IU per day improved liver inflammation in 43 percent of patients versus 19 percent on placebo. Pioglitazone improved it in 34 percent, though this just missed the trial’s pre-set threshold for statistical significance. Both reduced liver fat and inflammation on biopsy, but neither improved fibrosis scores.¹⁶

A systematic review of subsequent studies largely confirmed these findings: both drugs reduce fat buildup, inflammation, and ballooning in liver cells, but results on fibrosis remain mixed. One study suggested that combining pioglitazone with vitamin E may be more effective for resolving inflammation than pioglitazone alone.¹⁷ Pioglitazone carries the downside of potential weight gain and is generally reserved for people who also have type 2 diabetes. Vitamin E is available over the counter, but long-term high-dose use has raised safety concerns in other contexts, so this is not a supplement to start on your own without medical guidance.

Supplements With Mixed Evidence

Omega-3 fish oil is the supplement with the most research behind it for fatty liver, but the results are a mixed bag. Two meta-analyses found that omega-3 supplementation reduced liver fat based on pooled data, with one also showing improvement in the liver enzyme AST.¹⁸ ¹⁹ However, a randomized controlled trial in overweight men found no significant effect of fish oil on liver fat, liver enzymes, or body composition compared to placebo.²⁰ The discrepancy may come down to dose, duration, and the baseline characteristics of the people studied. At this point, omega-3s are a reasonable addition to a broader liver-friendly diet (or just eating more fatty fish), but they are not a standalone treatment.

Milk thistle (silymarin) is another popular option. A small trial in bariatric surgery candidates found that eight weeks of silymarin combined with calorie restriction led to improved ultrasound grading of fatty liver and drops in liver enzymes, though the fibrosis scores did not change meaningfully.²¹ The study was small and short, and the calorie restriction makes it difficult to separate the supplement’s contribution. Milk thistle is generally safe, but the evidence for it as a meaningful liver-fat reducer remains thin.

Coffee As a Protective Factor

Few dietary associations in liver research are as consistent as the one between coffee and reduced liver damage. A meta-analysis found that coffee consumption was linked to a 35 percent reduction in the odds of significant liver fibrosis.²² Another meta-analysis and review confirmed that drinking more than two cups per day in people with existing liver disease was associated with lower fibrosis, lower rates of liver cancer, and lower mortality.²³

This is observational data, so it cannot prove that coffee itself is the cause. But the association is strong, consistent across many studies, and shows a dose-response relationship. The likely mechanisms involve coffee’s antioxidant and anti-inflammatory compounds, not caffeine specifically, since decaf appears to retain some benefit. If you already drink coffee, there is no reason to stop. If you do not, starting coffee purely for your liver is a minor intervention compared to the dietary and exercise changes above, but it is not unreasonable.

When You Are Not Overweight but Still Have Fatty Liver

About 10 to 20 percent of people with fatty liver disease are not overweight by standard measures, a condition sometimes called “lean NAFLD” or lean MASLD. This is more common in people of South and East Asian descent, partly because of a body-composition pattern that favors more visceral fat relative to overall body size.²⁴ Lean and non-lean individuals with fatty liver share many of the same metabolic abnormalities, including insulin resistance and elevated liver enzymes, but they differ in genetic susceptibility and gut microbiome composition.²⁵

The treatment approach is essentially the same: improve overall fitness and reduce visceral fat, even if the total weight change is small. Exercise and dietary quality are if anything more important in lean fatty liver, because the typical first-line advice of “lose weight” may not obviously apply. Resistance training to build muscle, cutting refined carbohydrates and fructose, and addressing insulin resistance are the key strategies. Medications like GLP-1 agonists and resmetirom are also being studied in this population.

How Your Genetics Influence the Response

Not everyone responds equally to the same interventions, and genetics is one reason why. The most studied gene variant in this context is PNPLA3 I148M, which affects how the liver handles fat droplets. Carrying this variant increases your baseline risk of fatty liver, but it may also influence how well you respond to treatment. A systematic review found low-quality but suggestive evidence that people carrying two copies of the risk variant may actually respond better to lifestyle interventions for reducing liver fat than those without it.²⁶ A separate study found that the type of diet matters too: non-carriers saw a larger liver-fat reduction on a high-fat, reduced-carbohydrate diet compared to carriers who lost the same amount of weight.²⁷

None of this means you need genetic testing before starting treatment. The core interventions (weight loss, exercise, dietary improvement) help across all genotypes. But it helps explain why your friend might see dramatic improvement on the same plan that moves your numbers more slowly. If you are doing everything right and the response seems sluggish, genetics may be part of the picture, and it is worth discussing with your doctor rather than assuming you are doing something wrong.

The Gut Connection

Your liver receives most of its blood supply from the intestines through the portal vein, so whatever crosses the gut lining hits the liver first. Disruptions in the gut’s bacterial community, often driven by high-fat diets, can weaken the intestinal barrier and allow bacterial components like lipopolysaccharides to leak into the portal blood and reach the liver. Once there, these molecules trigger inflammation and can worsen fat accumulation and fibrosis.²⁸ ²⁹

This has practical relevance for dietary advice. High-fiber diets, fermented foods, and diverse plant intake all support a healthier gut bacterial community, which in turn may reduce the inflammatory load reaching the liver. Sleep disruption also factors in: obstructive sleep apnea, which is common in people with fatty liver, disrupts circadian rhythms and worsens glucose and lipid metabolism through pathways that overlap with the gut-liver connection.³⁰ If you snore heavily or wake unrefreshed, getting evaluated for sleep apnea and treating it may indirectly help your liver by restoring healthier metabolic rhythms.

Tracking Whether It Is Working

If you are making changes and want to know whether they are helping, the monitoring tools available vary in precision. Blood tests for liver enzymes (ALT and AST) are cheap and widely available, and a downward trend is encouraging, but they do not directly measure liver fat and can be normal even when significant fat remains. Ultrasound is the most common imaging tool; it can detect moderate and severe fatty liver but is not sensitive to small changes.

FibroScan (transient elastography) is increasingly used in clinics and gives two numbers: a controlled attenuation parameter (CAP) score that estimates fat content, and a liver stiffness measurement that estimates fibrosis. CAP values above roughly 275 dB/m suggest at least 10 percent liver fat, and values above 325 dB/m suggest more than 20 percent.³¹ FibroScan is useful for tracking trends over time, but MRI-based fat measurement (MRI-PDFF) is considerably more accurate for grading how much fat is actually in the liver.³² MRI is more expensive and not always needed, but if you are in a clinical trial or want precise before-and-after data, it is the gold standard. In a head-to-head comparison, MRI-PDFF significantly outperformed FibroScan’s CAP score for grading the severity of fat buildup.³³

For most people, a practical monitoring approach is a FibroScan every six to twelve months, combined with periodic blood work. If both the CAP score and your liver enzymes are trending down, you are on the right track. If one improves but the other does not, discuss further imaging with your doctor.